Randomised, Double-blind, Placebo-controlled Phase II Proof-of-concept Study of APD515 Solution for Oromucosal and Oral Administration for Relief of Xerostomia in Patients With Cancer

Trial Profile

Randomised, Double-blind, Placebo-controlled Phase II Proof-of-concept Study of APD515 Solution for Oromucosal and Oral Administration for Relief of Xerostomia in Patients With Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2013

At a glance

  • Drugs Bethanechol chloride (Primary)
  • Indications Xerostomia
  • Focus Therapeutic Use
  • Sponsors Acacia Pharma
  • Most Recent Events

    • 23 Oct 2013 New source identified and integrated: European Clinical Trials Database record.
    • 23 Oct 2013 New trial record
    • 15 Oct 2013 Positive results reported in an Acacia Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top